LivaNova PLC's stock had its IPO on October 19, 2015, making it an older stock than only 17.02% of US equities in our set.
With a year-over-year growth in debt of 165.54%, LivaNova PLC's debt growth rate surpasses 91.14% of about US stocks.
LivaNova PLC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -19.97%, greater than the shareholder yield of only 18.06% of stocks in our set.
Stocks that are quantitatively similar to LIVN, based on their financial statements, market capitalization, and price volatility, are LFUS, ROG, AMAG, OPK, and CPIX.
LIVN's SEC filings can be seen here. And to visit LivaNova PLC's official web site, go to www.livanova.com.
Artificial heart-lung machine, commonly known as Artificial Cardiopulmonary Machine or cardiopulmonary bypass pump, is used to take the role of the heart and lungs during any cardiovascular surgical procedure. The Artificial Cardiopulmonary Machine Market report is an extensive, proficient and
DUBLIN--(BUSINESS WIRE)--The "Neurology Devices Market 2019-2025" report has been added to ResearchAndMarkets.com's offering. The global neurology devices market is estimated to witness significant growth during the forecast period. Increasing demand for neurostimulation devices is one of the factors that are driving the market growth. Rising prevalence of neurological disorders, including Parkinson's and Alzheimer's disease has led the adoption of neurostimulation devices. In addition, rising